Skip to main content
. Author manuscript; available in PMC: 2010 Apr 17.
Published in final edited form as: Cancer Res. 2008 Feb 15;68(4):1170–1179. doi: 10.1158/0008-5472.CAN-07-2734

Figure 3.

Figure 3

rQT3 increased inhibition of tumor growth and prolonged survival. A, mice bearing small (left) or large (right) sporadic MPNST (STS26T) xenografts were treated with multiple i.t. doses of saline, G207, rQLuc, or rQT3 (arrows, 3 × 106 pfu/dose) and followed for tumor growth. B, NF-1–associated MPNST (S462.TY) xenografts were treated with saline or oHSV at 3 × 106 pfu/dose and followed for tumor growth (left) and survival (right). C, neuroblastoma (LA-N-5) xenografts were treated with saline or oHSV at 3 × 106 pfu/dose and followed for tumor growth. D, mice bearing dsRed-labeled MPNST (STS26T) xenografts were treated with oHSV as in A and imaged for in vivo tumor burden by ds-Red fluorescence at day 41.